Breaking News

PCI Builds New Clinical Storage and Distribution Facility

December 3, 2013

Expands North American operations

Packaging Coordinators Inc. (PCI) began construction of a new stand-alone clinical storage and global distribution facility in Rockford, IL, near its current facility. The new 93,000 sq.-ft. facility will allow PCI to provide additional capacity for both storage and global distribution. Construction is expected to be completed in mid-2014.   

The new distribution facility will support ambient and cold chain storage of investigational medicines and will be DEA approved for storage of Schedule II-V controlled substances. Also, its close proximity to the airport offers convenient international access. PCI currently distributes clinical/investigational medicines to investigator sites around the world and industry trends show continued growth of clinical studies in emerging markets such as South America, Asia, Russia, and Eastern Europe.

“We are very excited about the opportunity to build out our distribution capabilities in support of business growth,” said Bob Misher, senior vice president of Global Clinical Services at PCI. “The ability to package, store, globally distribute, and process returns of investigational medicines all in one state-of-the-art campus is a real benefit to our clients. This new facility helps us strategically position our business to further support industry trends we are witnessing; the first being international growth in the execution of our clients’ clinical studies, and the second being clients’ investigational medicines needing Cold Chain storage and shipment at 2-8°C, -20°C, and -80°C. We have been steadily expanding our capabilities in these areas as industry dynamics change. The location is built to be very accommodating as the industry and the needs of our clients evolve in years to come.”

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks